Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=17 Single-blind Treatment

TRE With Physical Activity for Weight Management

Pre Diabetes · Overweight and Obesity

Bottom Line

View on ClinicalTrials.gov: NCT04978376 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Body Weight Changes Between Week 1 to Week 10 — -2.1; -4.2; -1.3; .1 Percent body weight loss

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Time restricted eating (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Illinois at Chicago
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Body Weight Changes Between Week 1 to Week 10		 -2.1; -4.2; -1.3; .1 —
SECONDARY
Body Composition Changes From Week 1 to Week 10		 -3.5; -1.4; .7; -.3 —
SECONDARY
Change in Insulin From Week 1 to Week 10		 -.9; .6; .3; 2 —
SECONDARY
Glucose		 -.5; 1.5; -5; 1.7 —

Summary

Approximately 24 million older adults have prediabetes. Obesity, age related decreases in lean mass and increases in fat mass, and sedentary lifestyle have been associated with functional and cognitive decline in older adults. Innovative lifestyle strategies to treat obesity and pre-diabetes are critically needed. The proposed research will demonstrate that time restricted eating combined with resistance training is an effective non-pharmacological therapy to help obese prediabetic individuals reduce body fat, maintain lean mass, prevent progression of prediabetes to diabetes, and improve cognition.

Eligibility Criteria

Inclusion Criteria

  • Age between 50 to 70 years old
  • BMI between 25 and 50 kg/m2
  • Pre-diabetic or insulin resistant (fasting glucose: 100-125 mg/dl, HBA1c 5.7%-6.4%, or HOMA-IR >2.5)
  • Sedentary or lightly active 24
  • Are post menopausal (absence of menstrual cycle for 1 year)

Exclusion Criteria

  • Diabetic (fasting glucose: >126 mg/dl or HBA1c >6.5%)
  • Have a history of eating disorders (anorexia, bulimia, or binge eating disorder)
  • Have uncontrolled hypertension, any other cardiovascular disease, or history of aneurysm
  • History of alcohol dependance (score >20 from Alcohol and Health Questionnaire)25
  • Are not weight stable for 3 months prior to the beginning of study (weight gain or loss > 4 kg)
  • Are not able to keep a food diary or activity log for 7 consecutive days during screening
  • Are taking drugs that influence study outcomes (weight loss, glucose-lowering medications)
  • Are premenopausal, perimenopausal or have an irregular menstrual cycle (menses that does not appear every 27-32 days)
  • Mobility disability (unable to exercise for 40-60 minutes 3-5 days/week)
  • Diagnosed comorbidities including systemic diseases (Parkinson's cirrhosis, renal disease or systemic rheumatic conditions), cancer, or cognitive impairment
  • Are night shift workers
  • Are smokers
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04978376). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search